We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
+4.79%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$4.21B
AUM Growth
+$64.6M
Cap. Flow
-$99.3M
Cap. Flow %
-2.36%
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Avg Time Held
0.9 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$36.1M
2
ADT icon
ADT Corp
ADT
+$34.9M
3
PFE icon
Pfizer
PFE
+$27.7M
4
CB icon
Chubb
CB
+$19.3M
5
JCI icon
Johnson Controls International
JCI
+$15.1M

Top Sells

Rank Stock Value
1
LO
LORILLARD INC COM STK
LO
+$79.3M
2
MCRS
MICROS SYSTEMS INC
MCRS
+$73.6M
3
MSI icon
Motorola Solutions
MSI
+$51M
4
BHC icon
Bausch Health
BHC
+$23.5M
5
DTV
DIRECTV COM STK (DE)
DTV
+$15.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.03%
2 Consumer Discretionary 15.41%
3 Industrials 15.12%
4 Financials 11.91%
5 Technology 8.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
IHS icon
51
DELISTED
IHS INC CL-A COM STK
IHS
$14.3M 0.34%
105,085
– –
2013 Q2
4 quarters
TGT icon
52
Target
TGT
$71.2B
$14.1M 0.33%
242,815
+1,050
+0.4% +$61.8K
2013 Q2
4 quarters
LUMN icon
53
Lumen Technologies, Inc. Common Stock
LUMN
$5.02B
$13M 0.31%
358,400
+650
+0.2% +$23.3K
2013 Q4
2 quarters
DMLP icon
54
Dorchester Minerals
DMLP
$1.47B
$12.8M 0.3%
419,754
-2,100
-0.5% -$58.7K
2013 Q2
4 quarters
PNC icon
55
PNC Financial Services
PNC
$85.7B
$12.7M 0.3%
142,555
+425
+0.3% +$36.3K
2013 Q2
4 quarters
CPAY icon
56
Corpay
CPAY
$26.7B
$12.5M 0.3%
95,100
-9,990
-10% -$1.22M
2013 Q2
4 quarters
IEX icon
57
IDEX
IEX
$17.4B
$12.5M 0.3%
154,895
-300
-0.2% -$22.7K
2013 Q2
4 quarters
KMX icon
58
CarMax
KMX
$7.47B
$12.2M 0.29%
235,380
– –
2013 Q2
4 quarters
PSMT icon
59
Pricesmart
PSMT
$5.24B
$12.2M 0.29%
140,500
-60
-0% -$5.55K
2013 Q2
4 quarters
JWN icon
60
DELISTED
Nordstrom
JWN
$12.2M 0.29%
179,855
– –
2013 Q2
4 quarters
WP
61
DELISTED
Worldpay, Inc.
WP
$11.6M 0.28%
344,700
– –
2013 Q2
4 quarters
WAB icon
62
Wabtec
WAB
$48.6B
$11.6M 0.28%
140,135
-10,000
-7% -$771K
2013 Q2
4 quarters
T icon
63
AT&T
T
$161B
$11.6M 0.27%
432,955
+71,609
+20% +$1.92M
2013 Q2
4 quarters
GEF.B icon
64
Greif Class B
GEF.B
$4.18B
$11.5M 0.27%
192,614
+17,016
+10% +$1,000K
2013 Q2
4 quarters
R icon
65
Ryder
R
$9.21B
$11.5M 0.27%
130,350
+150
+0.1% +$12.6K
2013 Q2
4 quarters
PAA icon
66
Plains All American Pipeline
PAA
$17.7B
$11.1M 0.26%
184,909
– –
2013 Q2
4 quarters
XRAY icon
67
Dentsply Sirona
XRAY
$1.76B
$10.8M 0.26%
227,185
-1,000
-0.4% -$46.5K
2013 Q2
4 quarters
PRGO icon
68
Perrigo
PRGO
$2.29B
$10.6M 0.25%
72,560
+5
+0% +$708
2013 Q2
4 quarters
PCL icon
69
DELISTED
PLUM CREEK TIMBER CO (REIT)
PCL
$10.5M 0.25%
233,480
+24,580
+12% +$1.07M
2013 Q2
4 quarters
SIX icon
70
DELISTED
Six Flags Entertainment Corp.
SIX
$10.5M 0.25%
247,345
+5,000
+2% +$203K
2013 Q2
4 quarters
FAST icon
71
Fastenal
FAST
$57.8B
$10.5M 0.25%
846,400
– –
2013 Q2
4 quarters
DIN icon
72
Dine Brands
DIN
$418M
$10.4M 0.25%
131,250
+650
+0.5% +$51.3K
2013 Q3
3 quarters
MCD icon
73
McDonald's
MCD
$172B
$10.4M 0.25%
103,315
– –
2013 Q2
4 quarters
JAH
74
DELISTED
JARDEN CORPORATION
JAH
$10.3M 0.25%
261,248
– –
2013 Q2
4 quarters
AME icon
75
Ametek
AME
$57B
$10.3M 0.25%
197,685
– –
2013 Q2
4 quarters
1 2
3
4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q2 2014 Portfolio in Review

As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
  • Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
  • Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
  • Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
  • Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
  • Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
  • Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.

Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.